Many women experience hot flushes and night sweats around the time of menopause. Menopausal hormone therapy (MHT), also known as hormone replacement therapy (HRT) has been proven to be effective in alleviating these symptoms (3). Some women however, choose to explore complementary or herbal therapies for relief of symptoms. There have been a great many trials of complementary and herbal medicines and some of these have suggested benefits from certain therapies and others have shown no benefit. It can be difficult for consumers and for doctors to interpret this mixed information (4). This information sheet provides a brief overview of the current evidence for complementary and herbal therapies.
辅助和草药疗法有时referred to as “natural” and may be derived from plants and other sources. Some people believe that these products are safer than prescription products. However, scientific studies of these compounds have not supported this belief (4). Extracts from plants and other so-called “natural” products may actually cause harm and can interact with prescribed medicines (5).
They do not necessarily act like the hormones normally produced by women. Some over the counter treatments, including plant extracts, are not subject to the rigorous testing for content, safety and effectiveness that prescription treatments are subject to. Herbal products may contain heavy metals, illegal ingredients and toxic chemicals as well as naturally occurring organic toxins.
任何产品用于治疗更年期的年代ymptoms should have been shown in clinical studies to be effective. This usually requires a placebo-controlled trial or a head to head comparison with a known effective treatment or both. The placebo comparison is particularly important, because there is often a temporary placebo effect of most menopause treatments which commonly lasts around three months. Unless the product is tested for more than three months, it is not possible to say that it is truly effective for menopausal symptoms. This short-term placebo effect is quite different from the prolonged improvement in menopausal symptoms demonstrated by treatments such as MHTs which reduce hot flushes by around 90% and continue to be effective for as long as they are used (6). Prescription drugs cannot be licensed until they have been shown to be safe and effective. This is not the case for over the counter remedies for menopausal symptoms. The AMS advocates that all therapies whether prescription or alternative should not be used unless there is good research evidence for effectiveness and safety in the short and long term.
Herbal and Botanical therapies
Black Cohosh(Cimicifuga racemosa or Actaea racemosa)
A recent systematic review concluded that there is currently insufficient evidence to support the use of black cohosh for hot flushes. The effect of black cohosh on other important outcomes, such as health-related quality of life, sexuality, bone health, night sweats and cost-effectiveness is not yet established (7).
There were originally reports of liver toxicity (8), but these have not been seen in larger studies, and appear to be due to contaminants, though the longest study was only for six months (9).
Phytoestrogens including Red Clover (Trifolium pratense )
A wide range of products containing plant or phytoestrogens, including soy products, are available as over the counter remedies for hot flushes. Studies have varied widely in the dose and nature of compounds tested and the active product of these is thought to be isoflavones which bind to the oestrogen receptor and possess both oestrogen agonist and antagonist properties (1).Varied outcomes have been demonstrated with some short-term studies suggesting that there may be some benefit in using these products early in menopause but we are still lacking good long term studies. The available evidence suggests that isoflavones do not relieve long term menopausal vasomotor symptoms any better than placebo (10).
There is some evidence that questions the safety of these products in patients with breast cancer and phytoestrogen supplements may interfere with treatments for breast cancer (11).
Wild Yam Cream
There is very limited data on the use of wild yam cream for hot flushes. Existing studies do not show any efficacy in reducing menopausal symptoms (12) .
Evening Primrose Oil
Very few studies have addressed whether evening primrose oil improves hot flushes. Existing data shows no benefit (5, 13). Evening primrose oil lowers the seizure threshold in people with epilepsy and interferes with the actions of ant-epileptic medication (5).
No evidence of benefit for vasomotor symptoms (1).
Ginseng (Panax ginseng or Panax quinquefolius)
No evidence of benefit for vasomotor symptoms (1). Ginseng reduces the effects of immunosuppressive drugs, increases the effect of oral hypoglycaemic agents, potentiates the side effects of monoamine oxidase inhibitors and has an additive effect with benzodiazepines. Ginseng can also potentiate the action of warfarin (5).
Maca (Lepidium Meyennii Walp or Lepidium peruvianum Chacon)
Maca is a traditional foodstuff from South America with oestrogenic effects seen in vitro but not in vivo. Poor quality trials indicate improvement in menopausal symptom scores but there is insufficient evidence to support the use of Maca at this time (1).
Pine bark (Pycnogenol)
Pine bark derived from the Mediterranean pine (Pinus pinaster) is a source of proanthocyanidins (also found in grape seed). Pycnogenol is promising as improvement in menopausal symptom scores were observed in 3 short term RCTs using different doses but the effective dose and long term safety needs to be established (1).
There is insufficient evidence to support the use of pollen extract currently with only one small RCT reporting improvement in menopausal symptoms. Potential safety concerns relate to pollen allergy (1).
Siberian rhubarb is used for gastrointestinal complaints with some evidence that the hydrostilbenes in rhubarb act as serum oestrogen receptor modulators. Limited evidence form one small short term study indicated improvement in menopausal symptom score but further research is need to establish efficacy and safety (1).
Combination botanical therapies
Combination botanical therapies are purported to be superior as they address multiple menopausal symptoms (as does oestrogen in MHT). However, difficulties may arise in determining the potential for adverse events and drug-herb interactions. There is insufficient evidence regarding efficacy and safety to recommend their use currently (1).
Compounded bioidentical menopausal hormone therapy
复合激素含有hormona“瑞金”l preparations which are aimed at correcting “hormonal imbalances” which may occur at menopause. However, there is no evidence to support the effectiveness or safety of these products. Not only is evidence lacking to support superiority claims of compounded bioidentical hormones over conventional MHT, these claims also pose the additional risks of variable purity and potency, and lack efficacy and safety data. The Committee on Gynecologic Practice of the American College of Obstetricians and Gynecologists, the Practice Committee of the American Society for Reproductive Medicine and the US Endocrine Society have raised major concerns about the safety and efficacy of these products and recommend that patients be counselled to avoid their use (14) . (Please refer to AMS information sheetBioidentical hormones for menopausal symptoms)
Progesterone cream alone is not effective for the treatment of hot flushes because of unreliable absorption. (15).
Progesterone cream also does not provide sufficient endometrial protection if used in conjunction with exogenous oestrogen.
Vitamin E has not shown benefit in the treatment of menopausal hot flushes after breast cancer, and very limited efficacy in other women (16).
No evidence of benefit for vasomotor symptoms in short term studies (2).
No evidence of benefit for vasomotor symptoms in one RCT in women with breast cancer.
No evidence of benefit (2).
A number of prescribed medications have been shown in randomised clinical trials to be more effective than placebo in the treatment of hot flushes and night sweats. A summary of these treatments can be found in the AMS information sheetNonhormonal treatments for menopausal symptoms).
Lifestyle and Behavioural Modifications for Menopausal Symptoms
See AMS information sheetLifestyle and Behavioural Modifications for Menopausal Symptomsfor a summary of the evidence.
Cancer Australia’s Management of menopausal symptoms in women with a history of breast cancerhttps://canceraustralia.gov.au/publications-and-resources/clinical-practice-guidelines/menopausal-guidelines
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause2015; 22(11): 1155-72; quiz 73-4.
Memorial Sloan Kettering Cancer Center information on Integrative medicine including the “About Herbs App”
This is a USA site and not all of the products mentioned will be available in Australia.
- Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause.22(11):1155-72.
- Cancer Australia.https://www.canceraustralia.gov.au/publications-and-resources/clinical-practice-guidelines/menopausal-guidelines2016.
- Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;4:18.
- Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006;166(14):1453-65.
- Byard RW, Musgrave I, Maker G, Bunce M. What risks do herbal products pose to the Australian community? Med J Aust. 2017;206(2):86-90.
- Maclennan AH. Evidence-based review of therapies at the menopause. International Journal of Evidence Based Healthcare. 2009;7(2):112-23.
- Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;9:12.
- Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2002;177(8):440-3.
- Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte K-U, Osmers R. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause. 2011;18(4):366-75.
- Eden JA. Phytoestrogens for menopausal symptoms: a review. Maturitas. [Review]. 2012;72(2):157-9.
- Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis. 2008;29(11):2162-8.
- Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric. 2001;4(2):144-50.
- Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ. 1994;308(6927):501-3.
- American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, American Society for Reproductive Medicine Practice Committee. Compounded bioidentical menopausal hormone therapy. Fertil Steril. 2012;98(2):308-12.
- Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women. Menopause International. 2009;15(2):63-9.
- Rada G, Capurro D, Pantoja T, Corbalan J, Moreno G, Letelier LM, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;9:08.
Note:Medical and scientific information provided and endorsed by the Australasian Menopause Society might not be relevant to a particular person's circumstances and should always be discussed with that person's own healthcare provider.
这个信息表可能包含版权或不herwise protected material. Reproduction of this Information Sheet by Australasian Menopause Society Members and other health professionals for clinical practice is permissible. Any other use of this information (hardcopy and electronic versions) must be agreed to and approved by the Australasian Menopause Society.
Content Updated January 2018